Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.149
EU - Europa 2.607
AS - Asia 816
SA - Sud America 15
AF - Africa 8
Totale 7.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.131
IT - Italia 790
DE - Germania 521
SE - Svezia 393
SG - Singapore 342
IE - Irlanda 334
RU - Federazione Russa 208
CN - Cina 191
GB - Regno Unito 173
HK - Hong Kong 139
IN - India 40
FI - Finlandia 28
FR - Francia 27
VN - Vietnam 23
NL - Olanda 22
ID - Indonesia 18
UA - Ucraina 18
BE - Belgio 17
CA - Canada 17
MY - Malesia 17
AT - Austria 16
DK - Danimarca 16
BR - Brasile 11
CZ - Repubblica Ceca 10
IL - Israele 10
TR - Turchia 7
ES - Italia 6
PL - Polonia 6
SK - Slovacchia (Repubblica Slovacca) 6
IR - Iran 5
JP - Giappone 4
MM - Myanmar 4
RO - Romania 4
KR - Corea 3
NO - Norvegia 3
PK - Pakistan 3
SC - Seychelles 3
TW - Taiwan 3
CH - Svizzera 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
IQ - Iraq 2
LT - Lituania 2
PE - Perù 2
AR - Argentina 1
EC - Ecuador 1
EE - Estonia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 7.595
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.272
Frankfurt am Main 466
Fairfield 361
Dublin 318
Singapore 295
Milan 293
Chandler 292
Wilmington 265
Ashburn 180
Woodbridge 166
New York 145
Hong Kong 133
Houston 129
Seattle 126
Cambridge 118
Chicago 100
London 98
Princeton 98
Santa Clara 85
Shanghai 68
Dearborn 66
Altamura 46
Lawrence 46
Boardman 31
Rome 28
San Diego 26
Helsinki 23
Beijing 21
Florence 21
Pune 20
Jacksonville 19
Monza 19
Jakarta 18
Los Angeles 18
Brussels 16
Penang 16
Guangzhou 14
Bari 13
Nanjing 13
Turin 12
Vienna 12
Mumbai 11
Andover 10
Lissone 10
Bologna 9
Brno 9
Fremont 9
Dong Ket 8
Padova 8
São Paulo 8
Toronto 8
Modena 7
Munich 7
Naples 7
Central 6
Dallas 6
Dongguan 6
Jinan 6
Kocaeli 6
Somma Vesuviana 6
Udine 6
Amsterdam 5
Cagliari 5
Carate Brianza 5
Desio 5
Genoa 5
Hangzhou 5
Huizen 5
Lappeenranta 5
Marietta 5
Paris 5
Sacramento 5
Shenyang 5
Washington 5
Appiano Gentile 4
Atlanta 4
Bratislava 4
Castiglione del Lago 4
Council Bluffs 4
Hebei 4
Hefei 4
Meda 4
Moscow 4
Norwalk 4
Quanzhou 4
Rimini 4
Zhengzhou 4
Bergamo 3
Birmingham 3
Brescia 3
Changsha 3
Chioggia 3
Conversano 3
Cossato 3
Falls Church 3
Garbagnate Milanese 3
Gdansk 3
Haikou 3
Kilburn 3
Magdeburg 3
Totale 5.815
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 411
Better end points needed in primary sclerosing cholangitis trials 217
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 210
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 200
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 187
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 186
Precision medicine in primary biliary cholangitis 182
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 178
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 173
A second update on mapping the human genetic architecture of COVID-19 166
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 166
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 164
Risk stratification in primary sclerosing cholangitis 163
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 161
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 160
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 159
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 159
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 156
Mapping the human genetic architecture of COVID-19 153
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 150
New Therapeutic Targets in Autoimmune Cholangiopathies 149
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 149
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 144
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 139
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 137
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 133
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 129
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 126
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 125
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 120
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 118
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 118
The immunobiology of female predominance in primary biliary cholangitis 115
The application of artificial intelligence in hepatology: A systematic review 109
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 101
Cost of illness of Primary Biliary Cholangitis - a population-based study 100
Gender differences in liver disease and the drug-dose gender gap 99
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 99
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 94
The role of ethnicity in autoimmune hepatitis 89
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 87
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 82
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 81
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 79
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 78
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 76
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 73
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 71
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 66
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 65
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 59
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 57
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 55
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 51
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 50
Artificial intelligence for precision medicine in autoimmune liver disease 47
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 44
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 43
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 42
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 41
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 41
Artificial Intelligence and liver: Opportunities and barriers 40
Genetics of Primary Biliary Cholangitis 38
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 38
X marks the spot in autoimmunity 37
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 36
The Role of Epigenetics in Primary Biliary Cholangitis 34
The genetic architecture of primary biliary cholangitis 34
GWAS and autoimmunity: What have we learned and what next 33
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 33
Open challenges in the management of autoimmune hepatitis 30
Primary Sclerosing Cholangitis 29
Bacterascites confers poor patient prognosis beyond MELD prediction 26
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 23
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 20
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 19
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 19
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 18
Genetics of Autoimmune Liver Diseases 17
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 17
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 16
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 15
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 14
Incomplete normalization of transaminases at 18 months is the most important predictor for failure of biochemical response in autoimmune hepatitis 14
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 12
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 11
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 11
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 10
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 9
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 9
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 8
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 8
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 8
Primary Biliary Cholangitis 7
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 7
The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe 7
Cost of Illness of Primary Biliary Cholangitis in Lombardia 6
Totale 8.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020912 0 0 42 115 105 117 142 109 115 92 52 23
2020/20211.525 34 29 276 66 122 205 170 223 102 85 119 94
2021/20221.051 107 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/2025858 248 398 212 0 0 0 0 0 0 0 0 0
Totale 8.095